UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.197

Sortiert nach

Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024

PR newswire, 2024-05-24

2024

Link zum Volltext

Verfügbarkeit prüfen

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC Melanoma

PR newswire, 2024-05-23

2024

Link zum Volltext

Verfügbarkeit prüfen

EVEiQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

PR newswire, 2024-05-15

2024

Link zum Volltext

Verfügbarkeit prüfen

ESOC 2024: Higher income reduces stroke mortality risk by a third, new study shows

PR newswire, 2024-05-14

2024

Link zum Volltext

Verfügbarkeit prüfen

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications

PR newswire, 2024-05-13

2024

Link zum Volltext

Verfügbarkeit prüfen

Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"

PR newswire, 2024-05-10

2024

Link zum Volltext

Verfügbarkeit prüfen

Global Heart Hub's real-life data highlights need for patient-centered management of unhealthy cholesterol

PR newswire, 2024-05-08

2024

Link zum Volltext

Verfügbarkeit prüfen

Innosphere launches non-pharmaceutical ADHD clinical trial at top-tier research hospitals seeking pediatric patients

PR newswire, 2024-05-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress

PR newswire, 2024-04-29

2024

Link zum Volltext

Verfügbarkeit prüfen

Excellent Cancer Care, Exclusive Clinical Trials

PR newswire, 2024-04-23

2024

Link zum Volltext

Verfügbarkeit prüfen

AHN Physicians Become First in Western Pennsylvania to Implant Central Sleep Apnea Device

PR newswire, 2024-04-22

2024

Link zum Volltext

Verfügbarkeit prüfen

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

PR newswire, 2024-04-18

2024

Link zum Volltext

Verfügbarkeit prüfen

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX (testosterone undecanoate) CII Capsules

PR newswire, 2024-04-11

2024

Link zum Volltext

Verfügbarkeit prüfen

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

PR newswire, 2024-04-10

2024

Link zum Volltext

Verfügbarkeit prüfen

Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal

PR newswire, 2024-04-04

2024

Link zum Volltext

Verfügbarkeit prüfen

NEW RESEARCH FINDS ADULTS, CHILDREN AND TEENS WITH ECZEMA EXPERIENCE SIGNIFICANT MENTAL HEALTH SYMPTOMS

PR newswire, 2024-03-27

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular Robotics Market Share Analysis, Industry Trends Statistics and 10 Year Growth Forecasts 2019-2029

PR newswire, 2024-03-21

2024

Link zum Volltext

Verfügbarkeit prüfen

Senhwa Biosciences Announces First Patient Dosed in the Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia Associated with Viral Infection in Taiwan

PR newswire, 2024-03-20

2024

Link zum Volltext

Verfügbarkeit prüfen

U.S. FDA Oncologic Drugs Advisory Committee recommends CARVYKTI (ciltacabtagene autoleucel) for the earlier treatment of patients with relapsed or refractory multiple myeloma

PR newswire, 2024-03-15

2024

Link zum Volltext

Verfügbarkeit prüfen

New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications

PR newswire, 2024-03-12

2024

Link zum Volltext

Verfügbarkeit prüfen

World Vaccine Market Research Report 2023-2024 and 2030 - Increasing Consumer Awareness Towards Immunization Fueling Growth Amid Growing Prevalence of Infectious Diseases

PR newswire, 2024-03-11

2024

Link zum Volltext

Verfügbarkeit prüfen

Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market 10 Year Forecast Report 2024 - A $2.31 Billion Forecasted Market by 2034, Registering a CAGR of 5.12% During 2024-2034

PR newswire, 2024-03-08

2024

Link zum Volltext

Verfügbarkeit prüfen

Headlands Research Acquires Clinical Trial Site Pharmasite Research, Enhancing Therapeutic Expertise in Key Competencies

PR newswire, 2024-02-29

2024

Link zum Volltext

Verfügbarkeit prüfen

Inovalon's VigiLanz Solution Ranked No. 1 by KLAS Research in Pharmacy Surveillance and Infection Control and Monitoring

PR newswire, 2024-02-21

2024

Link zum Volltext

Verfügbarkeit prüfen

Harmonia Healthcare Launches with a Mission to Revolutionize Female Health

PR newswire, 2024-02-21

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.197

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Zeitschrift / SeriePr Newswire

ThemaMedicine, Experimental

Suchergebnisse filtern

Filter anzeigen

Publikationsform

Zeitungsartikel
(1.197)

Sprache

Englisch
(1.197)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nexis
(1.197)

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC Melanoma

EVEiQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

ESOC 2024: Higher income reduces stroke mortality risk by a third, new study shows

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications

Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"

Global Heart Hub's real-life data highlights need for patient-centered management of unhealthy cholesterol

Innosphere launches non-pharmaceutical ADHD clinical trial at top-tier research hospitals seeking pediatric patients

Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress

Excellent Cancer Care, Exclusive Clinical Trials

AHN Physicians Become First in Western Pennsylvania to Implant Central Sleep Apnea Device

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX (testosterone undecanoate) CII Capsules

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal

NEW RESEARCH FINDS ADULTS, CHILDREN AND TEENS WITH ECZEMA EXPERIENCE SIGNIFICANT MENTAL HEALTH SYMPTOMS

Molecular Robotics Market Share Analysis, Industry Trends Statistics and 10 Year Growth Forecasts 2019-2029

Senhwa Biosciences Announces First Patient Dosed in the Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia Associated with Viral Infection in Taiwan

U.S. FDA Oncologic Drugs Advisory Committee recommends CARVYKTI (ciltacabtagene autoleucel) for the earlier treatment of patients with relapsed or refractory multiple myeloma

New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications

World Vaccine Market Research Report 2023-2024 and 2030 - Increasing Consumer Awareness Towards Immunization Fueling Growth Amid Growing Prevalence of Infectious Diseases

Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market 10 Year Forecast Report 2024 - A $2.31 Billion Forecasted Market by 2034, Registering a CAGR of 5.12% During 2024-2034

Headlands Research Acquires Clinical Trial Site Pharmasite Research, Enhancing Therapeutic Expertise in Key Competencies

Inovalon's VigiLanz Solution Ranked No. 1 by KLAS Research in Pharmacy Surveillance and Infection Control and Monitoring

Harmonia Healthcare Launches with a Mission to Revolutionize Female Health

Aktive Filter

Suchergebnisse filtern